Clinical Trial Update: Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update for cannabidiol oral solution in Prader-Willi syndrome; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Cannabidiol Oral Solution (cannabidiol)

Snippet

Sponsor: Radius Pharmaceuticals, Inc. | Conditions: Prader-Willi Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2023-08-01